Hepatitis B virus infection in Tunisian pregnant women: Risk factors and viral DNA levels in HBe antigen negative women;Hépatite virale B chez les femmes enceintes tunisiennes : facteurs de risque et intérêt de l'étude de la réplication virale en cas d'antigène HBe négatif

Pathologie Biologie

Volumn 57, Issue 3, 2009, Pages

  Hannachi, N ^a   Bahri, O ^b   Mhalla, S ^a   Marzouk, M ^a   Sadraoui, A ^b   Belguith, A ^a   Triki, H ^b   Boukadida, J ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b PASTEUR INSTITUTE OF TUNIS   (Tunisia)

Author keywords

HBe antigen; Hepatitis B; Pregnant women; Risk factor; Seroprevalence; Viral replication

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ARTICLE; ENDEMIC DISEASE; FEMALE; HEPATITIS B; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANT WOMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SEROPREVALENCE; TUNISIA; VACCINATION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HUMANS; MANDATORY TESTING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TUNISIA; VIRAL LOAD;

EID: 64949096728     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2008.04.017     Document Type: Article

References (35)

1. World Health Organization. The World Health Report 1998.
2. Ranger-Rogez S., Alain S., and Denis F. Virus des hépatites : transmission mère-enfant. Path biol 50 9 (2002) 568-575
3. Denis F., Ranger-Rogez S., Tabaste J.L., Soulie J.C., and Goudeau A. Virus de l'hépatite B. In: Denis F. (Ed). Les virus transmissibles de la mère à l'enfant (1999), John Libbey Eurotext, Paris 85-103
4. Lee C., Gong Y., Brok J., Boxall E.H., and Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 332 7537 (2006) 328-336
5. Jordan R., and Law M. An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B. J Med Screen 4 3 (1997) 117-127
6. Hamdani-Belghiti S., and Bouazzaou N.L. Transmission mère-enfant du virus de l'hépatite B. État du problème et prévention. Arch Pediatr 7 (2000) 879-882
7. Del Canho R., Grosheide P.M., Mazel J.A., Heijtink R.A., Hop W.C., Gerards L.J., et al. Ten-year neonatal hepatitis B vaccination program. The Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 15 15 (1997) 1624-1630
8. Ngui S.L., Andrews N.J., Underhill G.S., Heptonstall J., and Teo C.G. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 27 1 (1998) 100-106
9. Raimondo G., Meucci G., Sardo M.A., Rodinò G., Campo S., Vecchi M., et al. Persistence of "wild-type" and "e-minus" hepatitis B virus infection in chronic healthy HBsAg/anti-HBe positive carriers. J Hepatol 20 1 (1994) 148-151
10. Jardi R., Rodriguez F., Buti M., Costa X., Cotrina M., Valdes A., et al. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepat 8 6 (2001) 465-471
11. Houissa R., Gharbi Y., Coursaget P., and El Goulli N. The epidemiology of hepatitis B in Tunisia. Arch Inst Pasteur Tunis 65 1-2 (1988) 53-58
12. Triki H., Said N., Ben Salah A., Arrouji A., Ben Ahmed F., Bouguerra A., et al. Seroepidemiology of hepatitis B, C and Delta viruses in Tunisia. Trans R Soc Trop Med Hyg 91 1 (1997) 11-14
13. Triki H. Epidemiology of hepatitis B virus, hepatitis C virus and Delta virus in the general population and in liver cirrhosis in Tunisia. Arch Inst Pasteur Tunis 71 3-4 (1994) 403-406
14. Triki H., Ben Slimane S., Ben Mami N., Sakka T., Ben Ammar A., and Dellagi K. High circulation of hepatitis B virus (HBV) precore mutants in Tunisia, North Africa. Epidemiol Infect 125 1 (2000) 169-174
15. Bahri O., Cheikh I., Hajji N., Djebbi A., Maamouri N., Sadraoui A., et al. Hepatitis B genotypes, precore and core promoter mutants circulating in Tunisia. J Med Virol 78 3 (2006) 353-357
16. Ayed K., Gorgi Y., Ayed-Jendoubi S., Aouadi H., Sfar I., Najjar T., et al. Hepatitis B virus genotypes and precore/core promoter mutations in Tunisian patients with chronic hepatitis B virus infection. J Infect 54 3 (2007) 291-297
17. Coursaget P., Gharbi Y., Khrouf N., Depril N., Boukhris N., Fritzell B., et al. Familial clustering of hepatitis B virus infections and prevention of perinatal transmission by immunization with a reduced number of doses in an area of intermediate endemicity (Tunisia). Vaccine 12 3 (1994) 257-258
18. Soltani M.S., Bchir A., Slimane M.N., Mtiraoui A., Ghanem H., Hammami M., et al. Mother-child transmission of hepatitis B virus in the Tunisian Sahel. Rev Epidemiol Santé Publique 42 6 (1994) 529-532
19. Bonura F., Sorgi M., Perna A.M., Puccio G., Tramuto F., Cajozzo C., et al. Pregnant women as a sentinel population to target and implement hepatitis B virus (HBV) vaccine coverage: a three-year survey in Palermo, Sicily. Vaccine 23 (2005) 3243-3246
20. Panagopoulos P., Economou A., Kasimi A., Spyropoulou P., Kanellopoulos N., Dadiotis L., et al. Prevalence of hepatitis B and C in the maternity department of a Greek district hospital. J Matern Fetal Neonatal Med 16 2 (2004) 106-110
21. Kuru U., Turan O., Kuru N., Saglam Z., Ceylan Y., Nurluoglu M., et al. Prevalence of hepatitis B virus infection in pregnant Turkish women and their families. Eur J Clin Microbiol Infect Dis 15 3 (1996) 248-251
22. Denis F., Ranger-Rogez S., Alain S., Mounier M., Debrock C., Wagner A., et al. Screening of pregnant women for hepatitis B markers in a French provincial university hospital (Limoges) during 15 years. Eur J Epidemiol 19 10 (2004) 973-978
23. Gutierrez-Zufiaurre N., Sanchez-Hernandez J., Munoz S., Marin R., Delgado N., Saenz M.C., et al. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin 22 9 (2004) 512-516
24. Christie A.B., Allam A.A., Aref M.K., Muntasser I.H., and El-Nageh M. Pregnancy hepatitis in Libya. Lancet 16 2 (1976) 827-829
25. El-Nawawy A., Soliman A.T., El Azzouni O., Amer e.-S., Karim M.A., Demian S., et al. Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis B antigens in an Egyptian rural area. J Trop Pediatr 42 3 (1996) 154-157
26. Shao Z.J., Xu D.Z., Xu J.Q., Li J.H., Yan Y.P., Men K., et al. Maternal hepatitis B virus (HBV) DNA positivity and sexual intercourse are associated with HBV intrauterine transmission in China: A prospective case-control study. J Gastroenterol Hepatol 22 2 (2007) 165-170
27. Sookoian S. Effect of pregnancy on preexisting liver disease: chronic viral hepatitis. Ann Hepatol 5 3 (2006) 190-197
28. Xiao X.M., Li A.Z., Chen X., Zhu Y.K., and Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynaecol Obstet 96 3 (2007) 167-170
29. Burk R.D., Hwang L.Y., Ho G.Y., Shafritz D.A., and Beasley R.P. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 170 (1994) 1418-1423
30. Soderstrom A., Norkrans G., and Lindh M. Hepatitis B virus DNA during pregnancy and postpartum: aspects on vertical transmission. Scand J Infect Dis 35 11-12 (2003) 814-819
31. Sangfelt P., Von Sydow M., Uhnoo I., Weiland O., Lindh G., Fischler B., et al. Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBe Ag-negative pregnant women. Scand J Infect Dis 36 3 (2004) 182-185
32. Elefsiniotis I.S., Glynou I., Magaziotou I., Pantazis K.D., Fotos N.V., Brokalaki H., et al. HBe Ag negative serological status and low viral replication levels characterize chronic hepatitis B virus-infected women at reproductive age in Greece: a one-year prospective single center study. World J Gastroenterol 11 31 (2005) 4879-4882
33. Bahn A., Hilbert K., Martine U., Westedt J., von Weizsacker F., and Wirth S. Selection of a precore mutant after vertical transmission of different hepatitis B virus variants is correlated with fulminant hepatitis in infants. J Med Virol 47 4 (1995) 336-341
34. Hawkins A.E., Gilson R.J., Beath S.V., Boxall E.H., Kelly D.A., Tedder R.S., et al. Novel application of a point mutation assay: evidence for transmission of hepatitis B viruses with precore mutations and their detection in infants with fulminant hepatitis B. J Med Virol 44 1 (1994) 13-21
35. Schaefer E., Koeppen H., and Wirth S. Low level virus replication in infants with vertically transmitted fulminant hepatitis and their anti-HBe positive mothers. Eur J Pediatr 152 7 (1993) 581-584